CHANDRESH SHAH: Open Payments
NPI 1770655987 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 15 payments from 9 companies in 2025. Trend: 2023 $647 · 2024 $505 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $178 |
| Imperative Care, Inc | 1 | $76 |
| Novo Nordisk Inc | 3 | $74 |
| UCB, Inc. | 1 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: BREZTRI, PRODIGY CATHETER, Ozempic, AIRSUPRA, Rystiggo, XHANCE, Quviviq, NUZYRA.
Industry payments across GA — which companies pay providers there.
